Patents by Inventor Eric Moellering

Eric Moellering has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240150800
    Abstract: The invention provides a recombinant algal organism that has been genetically modified in a gene encoding a protein kinase-like protein. The recombinant organism exhibits higher biomass productivity and higher lipid productivity versus a corresponding control algal organism not having the genetic modification. The recombinant organism is therefore useful in applications requiring biomass and/or lipid productivity, e.g. in the production of biofuels or other lipidic matter. Methods of using the organism and biomass containing or produced by the organism are also provided.
    Type: Application
    Filed: November 2, 2023
    Publication date: May 9, 2024
    Inventors: Saheed Imam, Eric Moellering, Luke Peach
  • Patent number: 11339399
    Abstract: The present invention provides cell lines for high efficiency genome editing using cas/CRISPR systems, methods of generating such cells lines, and methods of generating mutations in the genome of an organism using such cell lines.
    Type: Grant
    Filed: December 31, 2015
    Date of Patent: May 24, 2022
    Assignee: Viridos, Inc.
    Inventors: John Verruto, Eric Moellering
  • Patent number: 11124798
    Abstract: The present invention provides mutant microorganisms having attenuated expression of a gene encoding a polypeptide that includes a TPR domain, wherein the mutant microorganisms have higher lipid productivity and/or exhibit increased partitioning of carbon to lipid as compared to wild type microorganisms from which they are derived. Also provided are methods of producing lipids using the mutant microorganisms, guide RNAs, and nucleic acid constructs used for producing mutant microorganisms.
    Type: Grant
    Filed: December 7, 2018
    Date of Patent: September 21, 2021
    Assignee: Synthetic Genomics, Inc.
    Inventors: John Verruto, Eric Moellering, Imad Ajjawi
  • Publication number: 20210017530
    Abstract: The present invention provides cell lines for high efficiency genome editing using cas/CRISPR systems, methods of generating such cells lines and methods of generating mutations in the genome of an organism using such cell lines.
    Type: Application
    Filed: September 30, 2020
    Publication date: January 21, 2021
    Inventors: John Verruto, Eric Moellering
  • Publication number: 20190177738
    Abstract: The present invention provides mutant microorganisms having attenuated expression of a gene encoding a polypeptide that includes a TPR domain, wherein the mutant microorganisms have higher lipid productivity and/or exhibit increased partitioning of carbon to lipid as compared to wild type microorganisms from which they are derived. Also provided are methods of producing lipids using the mutant microorganisms, guide RNAs, and nucleic acid constructs used for producing mutant microorganisms.
    Type: Application
    Filed: December 7, 2018
    Publication date: June 13, 2019
    Inventors: John Verruto, Eric Moellering, Imad Ajjawi
  • Publication number: 20170191094
    Abstract: The present invention provides recombinant algae expressing exogenous Type I fatty acid synthase (FAS) genes and demonstrating higher rates of fatty acid synthesis with respect to control microorgansims. The recombinant algae are able to produce greater amounts of FAME lipids under nitrogen replete conditions.
    Type: Application
    Filed: December 29, 2016
    Publication date: July 6, 2017
    Inventors: Eric Moellering, Weidong Xu, John H. Verruto, Paul Gordon Roessler
  • Publication number: 20170073695
    Abstract: The present invention provides cell lines for high efficiency genome editing using cas/CRISPR systems, methods of generating such cells lines, and methods of generating mutations in the genome of an organism using such cell lines.
    Type: Application
    Filed: December 31, 2015
    Publication date: March 16, 2017
    Inventors: John Verruto, Eric Moellering
  • Patent number: 9328336
    Abstract: The present invention provides diacylglycerol acyltransferase (DGAT) genes, including genes encoding localization peptides. The present invention also provides recombinant cells, such as algae, transformed with DGAT genes and methods of using such recombinant cells to produce triglyceride.
    Type: Grant
    Filed: October 16, 2012
    Date of Patent: May 3, 2016
    Assignee: EXXONMOBIL RESEARCH AND ENGINEERING COMPANY
    Inventors: Jane C Schneider, Eric Moellering, Erik Holtzapple, Soyan Lieberman, Gena Roy
  • Publication number: 20140106417
    Abstract: The present invention provides novel diacylglycerol acyltransferase (DGAT) genes, including novel genes encoding localization peptides. The present invention also provides recombinant cells, such as algae, transformed with DGAT genes and methods of using such recombinant cells to produce triglyceride.
    Type: Application
    Filed: October 16, 2012
    Publication date: April 17, 2014
    Inventors: Jane C Schneider, Eric Moellering, Erik Holtzapple, Soyan Lieberman, Gena Roy